KindlyMD, Inc. (NASDAQ: KDLY) saw a significant increase in share price following the formal approval by shareholders of its proposed merger with the Bitcoin-native holding firm Nakamoto Holdings Inc. The stock of KDLY was up 29.24% to $19.67 as of the most recent pre-market check. This comes after it was announced that the majority of KindlyMD’s common shareholders had provided approval for the merger on May 18, 2025.
Using Strategic Integration to Promote the Adoption of Bitcoin
According to this agreement, an information statement will be sent to shareholders and filed with the U.S. Securities and Exchange Commission (SEC). The merger is anticipated to close around 20 days after the statement is sent. This deal unites the two businesses behind a same goal: for Bitcoin to establish itself as a major component of company balance sheets and a widely accepted asset that is available to investors worldwide.
The goal of David Bailey’s Nakamoto Holdings, which is connected to BTC Inc., is to establish a global network of treasury firms that specialize in Bitcoin. This project is part of a larger effort to create a strong network of Bitcoin-native businesses in the media, financial services, and advising industries.
Increasing Shareholder Value with a Bitcoin Yield Approach
The combined entity plans to pursue a Bitcoin treasury strategy designed to increase Bitcoin holdings on a per-share basis—a metric termed “Bitcoin Yield.” This will be achieved through a blend of equity, debt, and innovative financial instruments. With this merger, the public markets gain regulated exposure to Bitcoin, under the guidance of a seasoned leadership team well-versed in Bitcoin-centric corporate governance.
Healthcare Operations to Remain Unchanged Post-Merger
Despite the strategic shift, KindlyMD’s core healthcare services will continue uninterrupted. CEO Tim Pickett will maintain oversight of clinical operations, ensuring continuity in KDLY’s mission to combat the opioid crisis through integrative healthcare approaches. Clinics will retain their care teams and patient-focused ethos.
Upon completion of the merger, the new board will consist of six directors appointed by Nakamoto Holdings and one by KindlyMD, reflecting the structure of the newly unified vision.
Leave a Reply